Evaluation of the VITEK 2 System for Rapid Direct Identification and Susceptibility Testing of Gram-Negative Bacilli from Positive Blood Cultures
- 1 October 2003
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (10) , 4705-4707
- https://doi.org/10.1128/jcm.41.10.4705-4707.2003
Abstract
This study explores the possibility of combining the BacT/Alert Microbial Detection System with the VITEK 2 system to achieve rapid bacterial identification and susceptibility testing. Direct inoculation of bacterial suspension to the VITEK 2 ID-GNB card and AST-NO09 card was made by differential centrifugation of blood cultures of organisms with gram-negative enteric bacillus-like morphology. A total of 118 strains were investigated; of these, 97 (82.2%) strains were correctly identified to the species level and 21 (17.8%) strains were not identified; by comparing the results with those of the reference method of API identification systems using a pure culture, it was found that no strain had been misidentified. Among the 21 strains with no identification, 13 (61.9%) strains were nonfermenters. The direct-identification reporting time of VITEK 2 was 3.3 h. Direct testing of susceptibility to 11 antibiotics, i.e., amikacin, cefepime, ceftazidime, ciprofloxacin, gentamicin, imipenem, meropenem, netilmicin, piperacillin, piperacillin-tazobactam, and tobramycin, was also performed by using the broth microdilution (MB) method according to the NCCLS guidelines as a reference. After comparing the MICs of the VITEK 2 system with those obtained by the MB method within ±twofold dilution, it was determined that the 1,067 organism-antibiotic combinations had an overall correct rate of 97.6% (1,041 combinations). The rates of susceptibility to the 11 antibiotics ranged from 88.7 to 100%, respectively. Only two (0.2%) and four (0.4%) combinations of the susceptibility tests gave very major errors (i.e., reported as sensitive by the VITEK 2 system but shown to be resistant by the MB method) and major errors (i.e., reported as resistant by the VITEK 2 system but shown to be sensitive by the MB method), respectively. The reporting time for the direct testing of susceptibility against the 11 antibiotics for 97 blood culture isolates by the VITEK 2 system ranged from 3.3 to 17.5 h. Compared with conventional methods that require 1 or 2 days, this method can make same-day reporting possible and thus permit better patient management.Keywords
This publication has 22 references indexed in Scilit:
- Evaluation of the Vitek 2 System for Rapid Identification of Clinical Isolates of Gram-Negative Bacilli and Members of the Family StreptococcaceaeEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Direct identification and susceptibility testing of enteric bacilli from positive blood cultures using VITEK (GNI+/GNS-GA)Clinical Microbiology & Infection, 2002
- Evaluation of VITEK 2 Rapid Identification and Susceptibility Testing System against Gram-Negative Clinical IsolatesJournal of Clinical Microbiology, 2001
- The Use of Direct Susceptibility Tests from BACTEC 9240 to Microscan WalkawayJournal of Chemotherapy, 2001
- A 13-Year Study of Antimicrobial Susceptibility of Common Gram-Negative Bacteria Isolated from the Bloodstream in a Teaching HospitalChemotherapy, 2000
- Evaluation of an Automated System for Identification of Enterobacteriaceae and Nonfermenting BacilliEuropean Journal of Clinical Microbiology & Infectious Diseases, 1999
- The Clinical Significance of Positive Blood Cultures in the 1990s: A Prospective Comprehensive Evaluation of the Microbiology, Epidemiology, and Outcome of Bacteremia and Fungemia in AdultsClinical Infectious Diseases, 1997
- Antimicrobial Susceptibility Testing and Blood CulturesClinics In Laboratory Medicine, 1994
- Direct susceptibility testing of blood culture isolates with the automicrobic system (AMS)Diagnostic Microbiology and Infectious Disease, 1987
- Evaluation of a direct blood culture disk diffusion antimicrobial susceptibility testAntimicrobial Agents and Chemotherapy, 1981